重症心脏瓣膜病患者人工心脏瓣膜置换术术后预后影响因素分析

Abstract
Figure/Table
References (21)
Related Citation (15)

Download: PDF (443 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the risk factors affecting the prognosis of patients with advanced valvular hear disease after artificial cardiac valve replacement. Methods From January 2014 to December 2016, in Baoji Central Hospital, the clinical data of 200 patients with advanced valvular hear disease were retrospectively analyzed, the risk factors affect the postoperative prognosis of patients were analyzed. Results Regular follow-up was carried among all the 200 pa?鄄tients, the average follow-up time was (18.2±6.7) months, and 28 cases dead and 172 cases survived. Single factor analysis results showed that age, body mass index, cardiac functional grading, combined diabetes and kidney disease preoperative, protopathy,history of preoperative cardiac surgery, operation method, cardiopulmonary bypass time, time of arterial blocking between survival and dead patients had statistically significant difference (P < 0.05). Logistic multiple factors regression analysis results showed that age>60 years, body mass index<20 kg/m2 or >35 kg/m2, cardiac functional grade Ⅲ-Ⅳ, combined diabetes and kidney disease preoperative, protopathy,history of preoperative cardiac surgery, cardiopulmonary bypass time≥160 min, time of arterial blocking≥120 min were the influence factors ofprognosis of patients with severe valvular heart disease after artificial valve replacement. Conclusion Prognosis of patients with advanced valvular hear disease after artificial cardiac valve replacement can be influenced by many factors, so the positive and effective measures should be taken out to cope with the situation aimed at these factors,and to improve the prognosis of patients.

Key words： Advanced valvular hear disease Artificial heart valve replacement Prognosis Risk factors

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	MA En WANG Zongshe SHU Duanchao WANG Xiaojun ZHAO Long

Cite this article:

MA En WANG Zongshe SHU Duanchao WANG Xiaojun ZHAO Long. Analysis of the risk factors affecting prognosis of patients with advanced valvular hear disease afterartificial cardiac valve replacement[J]. 中国医药导报, 2017, 14(26): 64-67.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2017/V14/I26/64

[1] 张郁林，刘志勇，王冲，等.重症心脏瓣膜病外科手术治疗53例临床分析[J].现代医学，2005，33（3）：189-190.
[2] 张宝仁，朱家麟.人造心脏瓣膜与瓣膜置换术[M].北京：人民卫生出版社，1999.
[3] 颜海强.心脏瓣膜病治疗的现状与发展[J].福建医药杂志，2014，36（2）：140-141，143.
[4] 王杰.心脏瓣膜病患者瓣膜置换术远期预后的危险因素[J].中国现代药物应用，2014，8（17）：53-54.
[5] 林莹.人工瓣膜置换治疗重症心脏瓣膜病的效果观察[J].实用临床护理学电子杂志，2016，1（10）：96-97.
[6] Shirai S，Taniguchi T，Morimoto T，et al. Five-year clinical outcome of asymptomatic vs. symptomatic severe aortic stenosis after aortic valve replacement [J]. Circ J，2017， 81（4）：485-494.
[7] Javadikasgari H，Gillinov AM，Idrees JJ，et al. Valve repair is superior to replacement in most patients with coexisting degenerative mitral valve and coronary artery diseases [J]. Ann Thorac Surg，2017，103（6）：1833-1841.
[8] 钱军岭，王东进.重症心脏瓣膜病术后室性心律失常发生的危险因素分析[J].江苏医药，2015，41（12）：1417-1419.
[9] 李树松，方海宁，谭伟，等.重症心脏瓣膜病瓣膜置换术156例临床分析[J].广西医科大学学报，2010，27（6）：934-935.
[10] 黄园琴，李颖，刘彬，等.老年心脏瓣膜病患者的外科治疗[J].中西医结合心脑血管病杂志，2015，13（3）：403-404.
[11] 侯晓彤，孟旭，白涛，等.≥65岁老年人心脏瓣膜病的外科治疗[J].中华胸心血管外科杂志，2005，21（6）：325-327.
[12] Karim HMR，Yunus M，Saikia MK，et al. Incidence and progression of cardiac surgery-associated acute kidney injury and its relationship with bypass and cross clamp time [J]. Ann Card Anaesth，2017，20（1）：22.
[13] Griese DP，Kerber S，Barth S，et al. Impact of right and left ventricular systolic dysfunction on perioperative outcome and long-term survival after transcatheter aortic valve replacement [J]. J Interv Cardiol，2017，30（3）：217-225.
[14] 刘晓君，张涛，王刚，等.心脏瓣膜置换术合并冠脉搭桥术的危险因素分析[J].临床外科杂志，2015，23（9）：680-682.
[15] 侯艳娟，沈明敬，蔡立春，等.重症心脏瓣膜病瓣膜置换术后早期住院死亡的危险因素分析[J].中国循证心血管医学杂志，2016，8（5）：599-601.
[16] 罗纲，孙宏凯.重症瓣膜病合并心房颤动患者瓣膜置换术体外循环中单次给予胺碘酮对窦性心律转复和维持的影响[J].中国医药导报，2015，12（5）：77-80.
[17] 蓝善迪，莫述祥，谭燕慎，等.老年性心脏瓣膜病患者生存预后影响因素的研究[J].中西医结合心血管病电子杂志，2015，3（32）：81-82.
[18] Fornari AC，Fornari LH，Paiva JV，et al. Risk factors for hospital mortality in valve replacement with porcine bioprosthesis at an universitaryinstitution [J]. Rev Bras Cir Cardiovasc，2012，27（4）：583-591.
[19] Elmistekawy E，Rubens F，Hudson C，et al. Preoperative anaemia is a risk factor for mortality and morbidity following aortic valve surgery [J]. Eur J Cardiothorac Surg，2013，44（6）：1051-1055.
[20] 傅桂芬，韦靖，何静，等.心脏瓣膜病患者希望及自我管理水平对生活质量的影响研究[J].中国医药导报，2017， 14（12）：65-68.
[21] Johnson AP，Parlow J L，Whitehead M，et al.Body mass index，outcomes，and mortality following cardiac surgery in Ontario，Canada [J]. J Am Heart Assoc，2015，4（10）：e001977.